Excellent
Mostly Aligned
Patient Risk:
Low
Summary
The AI-generated claim is directly supported by the FDA label wording in Indications/Usage and is consistent with the drug-resistance risk warning in Warnings and Precautions (5.6). No contradictions or safety-relevant inaccuracies are identified.
Category Scores
Accurate Statements
Zmax should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria to reduce the development of drug-resistant bacteria.
Supported by Section 1 (Indications and Usage): “To reduce the development of drug-resistant bacteria... Zmax should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria.”
Prescribing Zmax in the absence of a proven or strongly suspected bacterial infection increases the risk of development of drug-resistant bacteria.
Consistent with Section 5.6 (Development of drug resistant bacteria): “Prescribing Zmax in the absence of a proven or strongly suspected bacterial infection... increases the risk of the development of drug-resistant bacteria.”
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The evaluated claim is aligned with labeled antimicrobial stewardship and resistance-risk warnings; it does not introduce off-label use, incorrect restrictions, or other safety-relevant deviations.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
None identified for this claim; alignment is essentially exact.
Suggested Improvement
Optionally cite both Section 1 and Section 5.6 explicitly when repeating stewardship language.